Compare Natera Inc. Common Stock (NTRA) vs SK Telecom Co. Ltd. Common Stock (SKM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs SK Telecom Co. Ltd. Common Stock — how do they compare? Natera Inc. Common Stock trades at $393.27 (market cap $57.03B), while SK Telecom Co. Ltd. Common Stock trades at $32.22 (market cap $13.02B). The key difference: Natera Inc. Common Stock is far larger — about 4.4× SK Telecom Co. Ltd. Common Stock's market cap, and SK Telecom Co. Ltd. Common Stock pays a 2.86% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and SK Telecom Co. Ltd. Common Stock for 6 Days on average.
| NTRA | SKM | |
|---|---|---|
Market Cap | $57.03B | $13.02B |
Volume | 1,131,157 | 1,394,041 |
Sector | Health | Media |
52-Week High | $425.64 | $46.00 |
52-Week Low | $179.42 | $19.68 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $56.18B | $19.07B |
Dividend Yield | — | 2.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
SKM trades at $34.42, up 2.9% today, showing strong earnings momentum with three consecutive quarterly beats. The stock faces technical headwinds with a bearish moving average signal despite oversold RSI conditions. Fundamentally, the company demonstrates robust gross margins of 87.51% but modest net income margins of 4.38%, with recent AI data center spin-offs creating potential value catalysts.
Outlook remains balanced with analyst consensus divided (42.85% Buy, 42.86% Hold) amid AI infrastructure expansion opportunities. Key risks include negative cash flow trends and competitive pressures in wireless communications. The current valuation at 24.39 P/E appears reasonable given growth initiatives, but execution on data center strategy will determine future performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About SK Telecom Co. Ltd. Common Stock
SK Telecom is a South Korean telecommunications company providing mobile, broadband, and digital services. It also develops services in areas such as AI, cloud, and data centers.
Read more on SKM →
